The present invention relates to compounds which activate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).
The present invention relates to compounds which activate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).
P53 ACTIVATING BENZOYL UREA AND BENZOYL THIOUREA COMPOUNDS
申请人:University Court of The University of Dundee
公开号:EP2099445A2
公开(公告)日:2009-09-16
US8501991B2
申请人:——
公开号:US8501991B2
公开(公告)日:2013-08-06
[EN] P53 ACTIVATING COMPOUNDS<br/>[FR] COMPOSÉS D'ACTIVATION DE P53
申请人:UNIV DUNDEE
公开号:WO2008029096A2
公开(公告)日:2008-03-13
(EN) The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).(FR) La présente invention concerne des composés qui activent la réponse de P53, et s'emploient, par exemple, dans le traitement de maladies hyperprolifératives comme le cancer et, éventuellement, d'autres maladies ou états (impliquant la fonction de la sirtuine).